Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: A randomized, double-blind, placebo-controlled phase III study

Journal of Clinical Oncology

Volumn 30, Issue 35, 2012, Pages 4337-4343

  Mariani, Pascale ^a   Blumberg, Joëlle ^c   Landau, Alain ^d   Lebrun Jezekova, Daniela ^e   Botton, Estelle ^f   Beatrix, Olivier ^g   Mayeur, Didier ^h   Herve, Robert ⁱ   Maisonobe, Pascal ^c   Chauvenet, Laure ^b  

^a INSTITUT CURIE   (France)

^b HÔTEL DIEU   (France)

^c IPSEN   (France)

^d Hopital Victor Jousselin   (France)

^e INSTITUT JEAN GODINOT   (France)

^f CENTRE EUGÈNE MARQUIS   (France)

^g CENTRE HOSPITALIER LYON SUD   (France)

^h CENTRE HOSPITALIER DE VERSAILLES   (France)

ⁱ Générale de Santé Hôpital Privé Clairval   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; CARCINOMATOUS PERITONITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; HUMAN; HYPOKALEMIA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; KIDNEY FAILURE; LUNG ASPIRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SIDE EFFECT; TREATMENT RESPONSE; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; MALE; PARTICLE SIZE; PEPTIDES, CYCLIC; PERITONEAL NEOPLASMS; PLACEBOS; SOMATOSTATIN;

EID: 84870753419     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.5712     Document Type: Article

References (13)

1. Laval G, Arvieux C, Stefani L, et al: Protocol for the treatment of malignant inoperable bowel obstruction: A prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 31:502-512, 2006 (Pubitemid 44192410)
2. Ripamonti C, Twycross R, Baines M, et al: Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9:223-233, 2001 (Pubitemid 32537280)
3. Feuer DJ, Broadley KE, Shepherd JH, et al: Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 3:CD002764, 2000
4. Feuer DJ, Broadley KE: Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev 3:CD001219, 1999
5. Harris AG: Somatostatin and somatostatin analogues: Pharmacokinetics and pharmacodynamic effects. Gut 35:S1-S4, 1994 (suppl 3)
6. Sobhani I, René E, Ramdani A, et al: Lanreotide inhibits human jejunal secretion induced by prostaglandin E1 in healthy volunteers. Br J Clin Pharmacol 41:109-114, 1996 (Pubitemid 26059124)
7. Kuhn JM, Legrand A, Ruiz JM, et al: Pharmacokinetic and pharmacodynamic properties of a long-acting formulation of the new somatostatin analogue, lanreotide, in normal healthy volunteers. Br J Clin Pharmacol 38:213-219, 1994 (Pubitemid 24282741)
8. Freeman GH, Halton JH: Note on exact treatment of contingency, goodness of fit and other problems of significance. Biometrika 38:141-149, 1951
9. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat Assoc 78:427-434, 1983
10. Hisanaga T, Shinjo T, Morita T, et al: Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction. Jpn J Clin Oncol 40:739-745, 2010
11. Massacesi C, Galeazzi G: Sustained release octreotide may have a role in the treatment of malignant bowel obstruction. Palliat Med 20:715-716, 2006
12. Ripamonti C, Mercadante S, Groff L, et al: Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: A prospective randomized trial. J Pain Symptom Manage 19:23-34, 2000 (Pubitemid 30067620)
13. Mercadante S, Casuccio A, Mangione S: Medical treatment for inoperable malignant bowel obstruction: A qualitative systematic review. J Pain Symptom Manage 33:217-223, 2007 (Pubitemid 46201883)